Regional clinical guidance for managing vitamin D deficiency and insufficiency in adults in Cornwall and IoS. Covers risk factors, supplementation advice, indications for testing, interpretation of vitamin D levels, and treatment with colecalciferol and calcium preparations. Includes loading and maintenance regimens, monitoring considerations, and guidance for malabsorption, renal disease and drug-induced deficiency. Developed and approved via CAPC in March 2018, with review scheduled for March 2021.
Free preview text
The first 5 pages, shown as text so search engines and readers can find this document.
Page 1
Note that OptimiseRx may prompt other products be considered for prescribing apart from those
named in this document.
CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D
DEFICIENCY& INSUFFICIENCY IN ADULTS
INTRODUCTION
Vitamin D is essential for skeletal growth and bone health. Dietary sources in the UK are very
limited and oily fish is the only significant source. Small amounts are provided by egg yolk, red
meat and fortified foods, such as some breakfast cereals and fat spreads (margarine). In
addition, infant formula milk has to be fortified with vitamin D (this is voluntary for formula milks
for toddlers). Breast milk contains very little vitamin D and is not a significant source. The major
natural source is from skin synthesis following exposure to sunlight. In a fair skinned person,
20-30 minutes of sunlight exposure to the face and forearms at midday generates about 2000
units of vitamin D. Two or 3 sunlight exposures per week are sufficient to achieve adequate
vitamin D levels in the summer if individuals have adequate levels to begin with. However,
those with low vitamin D levels, pigmented skin and the elderly need increased exposure time
or frequency to get the same level of vitamin D synthesis. Sun exposure should be avoided if
someone has a history of skin cancer, or conditions such as xeroderma pigmentosum or actinic
keratosis.
From mid-October to the beginning of April in the UK there is no ambient ultraviolet sunlight of
the appropriate wavelength. During this time, the population relies on both body stores from sun
exposure in the summer and dietary sources to maintain vitamin D levels.
The recommended oral daily intake of vitamin D for an adult in the UK is around 400IU (10mcg).
The average adult daily diet in the UK provides only 3.7mcg of vitamin D for men and 2.8mcg
for women. Food sources which contain greater than 5mcg per portion of vitamin D include 70g
sardines, 100g tinned salmon, pilchards or tuna, 110g of cooked mackerel or herring and 130g
cooked kipper. Consumption of food sources alone, in the absence of skin synthesis, will not
provide optimal vitamin D status. Vitamin D deficiency develops when there is inadequate
exposure to sunlight or a lack of vitamin D in the diet and usually takes a long time to develop
as there is slow release of the vitamin from body stores to cover times of deficiency.
Factors predisposing to Vitamin D deficiency:
Inadequate UV light exposure - Northern latitude, air pollution, habitual sunscreen use,
dark or pigmented skin, institutionalised/ housebound/ reduced mobility i.e. wheelchair
dependency, clothing which limits sunlight exposure or avoidance of sunlight
Poor dietary intake/ malabsorbtion - Poor diet, malabsorbtion including short bowel,
cholestatic jaundice, Crohn’s Disease, cystic fibrosis, coeliac disease, cholestyramine use
Metabolic risk - Reduced synthesis (eg over 65years old), pregnant and breastfeeding
women particularly teenagers and young women, multiple short interval pregnancies,
infants who are exclusively breast fed, obesity, increased breakdown eg drugs (rifampicin,
anticonvulsants particularly phenytoin or carbamazepine treatment, highly active
antiretroviral treatment, glucocorticoids), reduced stores: liver disease
Definition of Vitamin D Deficiency
Low vitamin D status (sometimes called vitamin D deficiency) is defined by the Department of
Health as a plasma concentration of 25 hydroxyvitamin D (the main circulating form of the
vitamin) of below 25 nmol/litre (equal to10 ng/ml). Several risk groups were identified in the
CMO guidance1 (2012) which recommended vitamin D supplementation of 400 units (10mcg)
daily to those groups of the population at risk of vitamin D deficiency.
1 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213703/dh_132508.pdf
Page 2
Note that OptimiseRx may prompt other products be considered for prescribing apart from those
named in this document.
This advice has been superseded by Public Health England (PHE) 2016 guidance2 which
advises people should consider taking a daily supplement containing 10 mcg of vitamin D in
autumn and winter, and people whose skin has little or no exposure to the sun, like those in
institutions such as care homes, or who always cover their skin when outside, risk vitamin D
deficiency and need to take a supplement throughout the year.
In these groups, supplementation is suggested without measurement of 25-OHD. For these
groups described above, the advice is to take an appropriate over the counter low
strength preparation of approximately 400 units which can be bought at low cost from
any pharmacy or health food shop. NB: multi-vitamin preparations and fish liver oils are not
suitable for the treatment of vitamin D deficiency as this may lead to vitamin A toxicity.
https://www.eclipsesolutions.org/UploadedFiles/318_KCCG_Vitamin-D-in-adults-information-
leaflet.pdf
PHE has also made recommendations for infants and children aged under 5 years.
The National Osteoporosis Society (NOS) have published a practical clinical guideline to
support health professionals with an aim to provide a uniform approach in the management of
adult patients with vitamin D deficiency.3 The guideline provides clarity on who should be tested
for vitamin D deficiency, how the results should be interpreted and how deficiency should be
treated. It is important to highlight that this clinical guideline intends to inform patient
management but not to influence public health policy.
WHEN TO MEASURE VITAMIN D LEVELS
Consider measuring vitamin D
In patients presenting with persistent musculoskeletal weakness, myalgia & arthralgia
Hypocalcaemia
Management of Primary Hyperparathyroidism
Unexplained osteoporosis/ osteoporosis refractory to treatment
Malabsorption syndromes
Please note: Requests by GPs for vitamin D testing require a clear indication / rationale for the
test. Re-testing after treatment is not currently considered necessary. When measuring vitamin
D levels, concurrent illness and seasonal factors should be considered. Recent illness or
operations may cause a falsely low reading.
Interpretation of vitamin D levels
A lack of national standards on whom to provide with additional vitamin D, when to test and how
to treat led to variations in guidance across the country. Recent advice from NOS provides
more consistency and makes recommendations on when testing is justified. In agreement with
the Institute of Medicine (IOM)4, they propose that the following vitamin D thresholds are
adopted by UK practitioners in respect to bone health;
2 https://www.gov.uk/government/news/phe-publishes-new-advice-on-vitamin-d
3 The National Osteoporosis Society. Vitamin D and bone health: A practical clinical guideline for
patient management. April 2013.
4 IOM (Institute of Medicine). Dietary Reference Intakes for Calcium and Vitamin D. A. Catharine
Ross, Christine L. Taylor, Ann L. Yaktine, and Heather B. Del Valle [Editors]. 2011.
Page 3
Note that OptimiseRx may prompt other products be considered for prescribing apart from those
named in this document.
>50 nmol/L of 25−OHD unlikely to require intervention
30–50 nmol/L of 25−OHD may be inadequate in some people
< 30 nmol/L of 25−OHD deficiency requiring treatment in adult patients
MANAGEMENT - Vitamin D Inadequacy (25-OHD 30-50nmol/l)
Treatment is advised in patients with the following:
fragility fracture, documented osteoporosis or high fracture risk
treatment with antiresorptive medication for bone disease
symptoms suggestive of vitamin D deficiency
increased risk of developing vitamin D deficiency in the future because of reduced
exposure to sunlight, religious/cultural dress code, dark skin, etc. – it is this group of
patients who are recommended to take a prophylactic over the counter dose of
400 units
raised PTH
medication with antiepileptic drugs or oral glucocorticoids
conditions associated with malabsorption.
Where vitamin D alone is required, there is no need for the high dose regime and 800-1,600
units of colecalciferol daily is adequate. It may take up to 3 months to replenish stores. Routine
monitoring is not required for vitamin D doses ≤2000 units daily.
Clinicians should use the cheapest preparation available after consideration of clinical
indications and potential risks.
Stexerol D3 tablet
25mcg vitamin D3 (1000 units
colecalciferol)
Lower cost product
Licensed UK
product
Colecalciferol is derived from healthy
live sheep’s wool fat – may be
acceptable to vegetarians
Fultium D3 capsule
20mcg vitamin D3 (800 units
colecalciferol)
Higher cost product
Licensed UK
product
Contains glycerol and gelatin.
The gelatin used in the capsule shell
is certified to Halal standards
Desunin tablet
20mcg vitamin D3 (800 units
colecalciferol)
Higher cost product
Licensed UK
product
Does not contain gelatin, peanut oil or
soya. Colecalciferol is derived from
healthy live sheep’s wool fat – may be
acceptable to vegetarians
For bone health, calcium and vitamin D3 800 units/day is appropriate. Locally agreed products
are as below, though RCHT may not stock the complete range listed.
Calceos chewable tablet
calcium 500mg and 10 mcg
vitamin D3 (400 units)
Licensed UK
product
One tablet twice a day
Calfovit D3 powder in sachet
Calcium 1.2g and 20 mcg
vitamin D3 (800 units)
Licensed UK
product
One sachet daily
Adcal D3 chewable tablet
calcium 600mg and 10 mcg
vitamin D3 (400 units)
Licensed UK
product
One tablet twice a day
Calcichew D3 caplet
calcium 500mg and 10 mcg
vitamin D3 (400 units)
Licensed UK
product
One tablet twice a day
Page 4
Note that OptimiseRx may prompt other products be considered for prescribing apart from those
named in this document.
MANAGEMENT - Vitamin D deficiency (25-OHD <30nmol/L)
For patients with symptoms of deficiency the recommended treatment is based on fixed loading
doses of vitamin D (up to a total of about 300,000 units) given either as weekly or daily split
doses, followed by lifelong maintenance treatment of about 800 units a day. Higher doses of up
to 2000 units a day, occasionally up to 4000 units a day, may be used for certain groups of
people, for example those with malabsorption disorders.
Several treatment regimens are available, including 50,000 units once a week for 6 weeks
(300,000 units in total), 20,000 units twice a week for 7 weeks (280,000 units in total), or 4000
units daily for 10 weeks (280,000units in total). Locally agreed products are as follows:
Fultium D3 capsule
500 mcg vitamin D3 (20,000
units colecalciferol)
Licensed UK
product
Contains glycerol and gelatin.
The gelatin used in the capsule shell
is certified to Halal standards
InVita D3 oral solution
625 mcg vitamin D3 (25,000
units colecalciferol) per 1ml unit
amp oral solution
Licensed UK
product
Colecalciferol is derived from healthy
live sheep’s wool fat – may be
acceptable to vegetarians
Maintenance therapy can begin immediately after the completion of the high dose phase. It is
recommended to check calcium and phosphate 4 weeks following the initiation of the high dose
phase in case primary hyperparathyroidism has been unmasked.
Routine repeat of vitamin D levels is not needed if symptoms of vitamin D deficiency resolve. If
symptoms do not resolve despite adequate vitamin D repletion then the symptoms are not due
to vitamin D deficiency.
Patients with high or high-normal calcium levels and vitamin D deficiency may have coexistent
primary hyperparathyroidism. Consider referral to a specialist clinic with an interest in calcium
eg Endocrine.
Patients with significant hypomagnesaemia (Mg2+ <0.5mmol/l) from any cause may develop
significant hypocalcaemia due to ineffective release of PTH. PTH measurement is not
recommended in patients with severe hypomagnesaemia as it may be uninterpretable.
Replacement with combination magnesium and activated vitamin D may be necessary - seek
specialist help.
Alfacalcidol or calcitriol should NOT be used for routine treatment of vitamin D
deficiency as they carry a higher risk of toxicity and require close monitoring.
Malabsorption syndromes
Oral therapy is more effective than IM injections except in cases of significant malabsorption.
Options include:
High dose oral therapy e.g. 20,000 units - 25,000 units oral colecalciferol weekly
IM injection of ergocalciferol. Initially 300,000 units IM injections 3 months apart followed
by maintenance treatment of 300,000 units IM 6 monthly (a licensed product). If the
injection is used, close monitoring of serum and urinary calcium, phosphate and renal
function is needed to avoid hypercalcaemia.
Renal disease
Patients on haemodialysis at RCH have their vitamin D levels reviewed and replaced as
necessary as part of their dialysis care, and therefore will be excluded from this guideline.
Page 5
Note that OptimiseRx may prompt other products be considered for prescribing apart from those
named in this document.
Drug induced vitamin D deficiency
If the patient is taking drugs that accelerate Vitamin D metabolism or if there are concerns
regarding absorption, then, higher doses may be required. The Medicines and Healthcare
Regulatory Agency have advised that patients on long-term anticonvulsant therapy require
vitamin D supplementation 400 units daily as a prophylaxis.
Guidance developed & approved via CAPC March 2018. For review March 2021
Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults: summary, contents and background
This guide helps you understand the scope of Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.
Summary and overview
Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults is a 5-page documentcredited to Juno Y. Merrick. Regional clinical guidance for managing vitamin D deficiency and insufficiency in adults in Cornwall and IoS. Covers risk factors, supplementation advice, indications for testing, interpretation of vitamin D levels, and treatment with colecalciferol and calcium preparations. Includes loading and maintenance regimens, monitoring considerations, and guidance for malabsorption, renal disease and drug-induced deficiency. Developed and approved via CAPC in March 2018, with review scheduled for March 2021. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.
The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Vitamin D deficiency, Vitamin D insufficiency, Adult clinical guidance, Bone health, Colecalciferol, Vitamin D testing, Cornwall & IoS with the related resources linked below.
Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.
Key topics and reader takeaways
The catalogue connects this document with Vitamin D deficiency, Vitamin D insufficiency, Adult clinical guidance, Bone health, Colecalciferol, Vitamin D testing, Cornwall & IoS. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.
A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.
Table of contents and reading guide
The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 5 pages in the player.
Part 1
Vitamin D deficiency
Use this section of the reading guide to identify how Vitamin D deficiency appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 2
Vitamin D insufficiency
Use this section of the reading guide to identify how Vitamin D insufficiency appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 3
Adult clinical guidance
Use this section of the reading guide to identify how Adult clinical guidance appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 4
Bone health
Use this section of the reading guide to identify how Bone health appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 5
Colecalciferol
Use this section of the reading guide to identify how Colecalciferol appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 6
Vitamin D testing
Use this section of the reading guide to identify how Vitamin D testing appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
Part 7
Cornwall & IoS
Use this section of the reading guide to identify how Cornwall & IoS appears in Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, note important terms, and connect the subject to the wider purpose of the work.
When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.
About Juno Y. Merrick
Doxxly credits Juno Y. Merrick as the author or creator of Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.
Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.
About the source organisation
The recorded source for this item is eclipsesolutions.org. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.
Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.
Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.
The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.
If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.
Research questions to consider
As you read Cornwall & IoS Guideline for the Management of Vitamin D Deficiency & Insufficiency in Adults, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.
A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.
Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.